Aerpio Pharmaceuticals, Inc. (ARPO) Stock Analysis
DELISTED 2021
What happened to Aerpio Pharmaceuticals, Inc. (ARPO) stock?
Aerpio Pharmaceuticals, Inc. (ARPO) no longer trades on public markets. It was delisted in August 2021. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- August 2021
- Last recorded price (historical):
- $2.20 (last quote on record before the August 2021 delisting; historical, not a current quote)
Market cap $53.7M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Aerpio Pharmaceuticals, Inc. (ARPO). Aerpio Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing treatments for ocular diseases. Their lead product candidate, AKB-9778, targets diabetic retinopathy, with other pipeline programs addressing inflammatory bowel disease.
Last analyzed: Mar 18, 2026These figures come from statements filed 13 months ago — the most recent this company has published.
Aerpio Pharmaceuticals, Inc. (ARPO) Healthcare & Pipeline Overview
More about this archive record
Can I still buy ARPO shares?
No. ARPO stopped trading on public markets in August 2021, so the shares are not available through a broker. Anything you see quoted for ARPO elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before ARPO stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Aerpio Pharmaceuticals, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.